<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.appliedneuroscience.org.au/page-65867/EventModule/65867/RSS" rel="self" type="application/rss+xml" />
    <title>ANSA upcoming events</title>
    <link>https://www.appliedneuroscience.org.au/events</link>
    <description>ANSA upcoming events</description>
    <dc:creator>ANSA</dc:creator>
    <generator>Wild Apricot - membership management software and more</generator>
    <language>en</language>
    <pubDate>Fri, 05 Jun 2026 03:42:06 GMT</pubDate>
    <lastBuildDate>Fri, 05 Jun 2026 03:42:06 GMT</lastBuildDate>
    <item>
      <pubDate>Mon, 23 Feb 2026 13:00:00 GMT</pubDate>
      <title>Member Forum Registration 2026 (24 Feb 2026)</title>
      <description>&lt;!-- =========================================  ANSA Member Forum (Google Groups) – Wild Apricot Event Page HTML  Paste into the Event "Description" (HTML mode).  Replace the banner placeholder URL + Google Group URL when ready.  ========================================= --&gt;

&lt;div style="max-width: 900px; margin: 0px auto; font-family: Arial, Helvetica, sans-serif; line-height: 1.5;"&gt;
  &lt;!-- Banner (placeholder) --&gt;

  &lt;div style="color: rgb(34, 34, 34); margin: 0px 0px 18px;"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/Pictures/ANSA%20LOGO.jpg" alt="ANSA banner" style="width: 100%; height: auto; border-radius: 8px; display: block;"&gt;&lt;/div&gt;&lt;!-- Title --&gt;

  &lt;h2 style="color: rgb(34, 34, 34); margin: 0px 0px 8px; font-size: 24px;"&gt;ANSA Member Forum Access Registration&lt;/h2&gt;

  &lt;p style="color: rgb(68, 68, 68); margin: 0px 0px 18px; font-size: 14px;"&gt;This event is used to register for access to the &lt;strong&gt;ANSA Member Forum&lt;/strong&gt;, hosted in &lt;strong&gt;Google Groups&lt;/strong&gt;. The forum is a member benefit and only active members will be provided access.&lt;/p&gt;&lt;!-- Key requirement callout --&gt;

  &lt;div style="color: rgb(51, 51, 51); background: rgb(255, 243, 205); border: 1px solid rgb(255, 230, 156); padding: 14px 16px; border-radius: 8px; margin: 0px 0px 18px;"&gt;
    &lt;h3 style="margin: 0px 0px 8px; font-size: 16px;"&gt;&lt;font color="#000000"&gt;Important: Use your Google-linked email address&lt;/font&gt;&lt;/h3&gt;

    &lt;p style="color: rgb(34, 34, 34); margin: 0px;"&gt;&lt;strong&gt;Members must register using the email address they use with Google&lt;/strong&gt; to access the Forum. If your ANSA membership email is different, please ensure you register here with your &lt;strong&gt;Google email&lt;/strong&gt;.&lt;/p&gt;
  &lt;/div&gt;&lt;!-- What happens next --&gt;

  &lt;div style="background: rgb(247, 247, 247); border: 1px solid rgb(229, 229, 229); padding: 14px 16px; border-radius: 8px; margin: 0px 0px 18px;"&gt;
    &lt;h3 style="margin: 0px 0px 10px; font-size: 16px;"&gt;&lt;font color="#0000FF"&gt;After you register&lt;/font&gt;&lt;/h3&gt;

    &lt;ol style="color: rgb(34, 34, 34); margin: 0px; padding-left: 18px;"&gt;
      &lt;li&gt;ANSA will confirm your membership status.&lt;/li&gt;

      &lt;li&gt;You will be added to the Google Group using the email you register with on this page.&lt;/li&gt;

      &lt;li&gt;You can then set your email frequency preferences inside Google Groups (each email, digest, abridged, or no email).&lt;/li&gt;
    &lt;/ol&gt;&lt;!-- Optional link placeholders --&gt;&lt;br&gt;
  &lt;/div&gt;&lt;!-- Rules --&gt;

  &lt;h3 style="color: rgb(34, 34, 34); margin: 0px 0px 10px; font-size: 18px;"&gt;Forum Rules&lt;/h3&gt;

  &lt;div style="color: rgb(34, 34, 34); border: 1px solid rgb(229, 229, 229); border-radius: 8px; padding: 14px 16px; background: rgb(255, 255, 255);"&gt;
    &lt;p style="margin: 0 0 12px 0;"&gt;&lt;strong&gt;Welcome to the Applied Neuroscience Society of Australasia (ANSA) Member Forum!&lt;/strong&gt; To ensure a productive and respectful environment, we ask that all members adhere to the following rules:&lt;/p&gt;

    &lt;ol style="margin: 0; padding-left: 18px;"&gt;
      &lt;li&gt;&lt;strong&gt;Content:&lt;/strong&gt; Please only use this Forum for professional exchange on all matters of applied neuroscience, neuromodulation, neurofeedback. We welcome information and resource sharing, questions and collegial networking.&lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Classifieds:&lt;/strong&gt; Members wishing to share resources including products, training and services relevant to the ANSA community may post such information once per month. Only services, products or events related to brain function, health, neuroscience, biofeedback , assessment and/or treatment are able to be shared on this Forum. For such posts, the subject line MUST begin with the word: “Advertisement”.&lt;/li&gt;

      &lt;li&gt;
        &lt;strong&gt;Confidentiality:&lt;/strong&gt;

        &lt;ol type="a" style="margin: 8px 0 0 0; padding-left: 18px;"&gt;
          &lt;li&gt;&lt;strong&gt;Member privacy:&lt;/strong&gt; Forum postings are not permitted to be forwarded to anyone outside of the subscribed users;&lt;/li&gt;

          &lt;li&gt;&lt;strong&gt;Client privacy:&lt;/strong&gt; if seeking specific consultation advice or referral options for a specific client, this Forum is not the appropriate place. Please ask (and share) about topics and information related to neuromodulation, but without reference to specific client characteristics which may compromise confidentiality, or which could be construed as a request for consultation on particular client.&lt;/li&gt;
        &lt;/ol&gt;
      &lt;/li&gt;

      &lt;li&gt;
        &lt;strong&gt;Forum etiquette:&lt;/strong&gt;

        &lt;ol type="a" style="margin: 8px 0 0 0; padding-left: 18px;"&gt;
          &lt;li&gt;&lt;strong&gt;Know your audience:&lt;/strong&gt; Please consider whether your post will add to the discussion in an informative way that will be of value to others, or whether it is best to send it privately. Please refrain from posting administrative messages “thank you,” “me too”, “remove me from the list” or personal comments that are directed only to the individual who sent the email. Before you send your message, check the “To:” field to determine if your message is addressed to the whole list or just the sender of the email.&lt;/li&gt;

          &lt;li&gt;&lt;strong&gt;Use the subject line:&lt;/strong&gt; Make the subject line descriptive so that recipients have a flavour of the message from glancing at the subject line, and can search archives by subject.&lt;/li&gt;

          &lt;li&gt;&lt;strong&gt;Respect and courtesy:&lt;/strong&gt; Treat all members with respect and courtesy. Disagreement is a natural part of professional discourse, but personal attacks, insults, or inflammatory comments are not appropriate for this Forum. Users may not use language or post content that is, including but not limited to, unlawful, harassing, abusive, defamatory, obscene, scandalous, inflammatory, pornographic or profane, or otherwise unprofessional. Users also should be cautious with humour and sarcasm in this professional Forum.&lt;/li&gt;
        &lt;/ol&gt;
      &lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Email Frequency:&lt;/strong&gt; We want this Forum to bring members together, but we all have different preferences for email frequency. Choose the option that suits you (each email / digest or abridged / no email), by managing your subscriptions in Google Groups (be sure to use the email address your ANSA membership is linked to), click the Down arrow for the ANSA_Member_Forum.&lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Responsibility and warranties:&lt;/strong&gt; Forum members acknowledge that they are responsible for the information they submit and have full responsibility for the posting, including its legality, reliability, appropriateness, originality, and copyright. ANSA as a society accepts no responsibility for opinions and information posted on the Forum. ANSA disclaims all warranties with regard to information posted on this site. In no event shall ANSA be liable for any damages resulting from or in connection with the use of information posted on this site. Posts to the Forum are not legal advice, nor should any professional or clinical information shared on the Forum be relied upon by providers in their practice, without independent professional consultation. General information shared on the Forum is not a substitute for consulting a professional mentor or supervisor when this might be required. ANSA bears no responsibility for the opinions or information posted on the Forum, or their accuracy. The use of this ANSA Member Forum does not create supervisory or mentoring relationships. ANSA makes no warranties regarding the confidentiality of messages sent to the Forum. Users cannot assume that confidential or sensitive information posted to this Forum will remain so.&lt;/li&gt;

      &lt;li&gt;
        &lt;strong&gt;Defamation:&lt;/strong&gt; Do not post defamatory content on the Forum. Members are reminded that defamation laws in Australia prohibit the publication of false statements that harm the reputation of individuals or organizations. Be cautious in discussing legal, business, or personal matters. If unsure, seek moderator approval before posting. All members are personally responsible for the content they share and may be held liable for any defamatory material. This includes:

        &lt;ol type="a" style="margin: 8px 0 0 0; padding-left: 18px;"&gt;
          &lt;li&gt;False claims or accusations about other members, individuals, or entities;&lt;/li&gt;

          &lt;li&gt;Any unsubstantiated statements that could damage someone's reputation.&lt;/li&gt;
        &lt;/ol&gt;
      &lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Copyright:&lt;/strong&gt; Users may not post information or other material that is protected by copyright or use any words, logos, or other marks that would infringe upon a trademark or other intellectual property rights without permission of the owners.&lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Moderation:&lt;/strong&gt; ANSA reserves the right to moderate discussions, remove posts, or suspend members who violate the rules or ethical guidelines. Repeated or severe breaches of these rules, including violations of defamation laws, may result in permanent removal from the Forum. ANSA reserves the right to modify or discontinue the Forum at any time. The lists of subscribers also will be audited periodically to maintain the security and integrity of the Forum for the benefit of the members.&lt;/li&gt;

      &lt;li&gt;&lt;strong&gt;Reporting Violations:&lt;/strong&gt; please report any issues, questions or violations of these rules or the Ethical Code of Conduct, to the Forum moderator or &lt;a href="mailto:secretary@appliedneuroscience.org.au"&gt;secretary@appliedneuroscience.org.au&lt;/a&gt;.&lt;/li&gt;
    &lt;/ol&gt;

    &lt;p style="margin: 14px 0 0 0;"&gt;By participating in this Forum, you agree to adhere to these rules and engage in a manner that reflects the professional standards of ANSA.&lt;/p&gt;
  &lt;/div&gt;&lt;!-- Footer note --&gt;

  &lt;p style="color: rgb(85, 85, 85); margin: 18px 0px 0px; font-size: 13px;"&gt;If you are registering on behalf of yourself, please double-check your registration email is the one you use for Google access to Groups.&lt;/p&gt;
&lt;/div&gt;</description>
      <link>https://appliedneuroscience.org.au/event-6581349</link>
      <guid>https://appliedneuroscience.org.au/event-6581349</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Fri, 11 Sep 2026 22:30:00 GMT</pubDate>
      <title>ANSA 2026 Conference (12 Sep 2026)</title>
      <description>&lt;style&gt;#ansa-reg { --navy: #0a1628; --navy-mid: #132040; --navy-light: #1e3160; --gold: #c8922a; --gold-light: #e8b14a; --gold-pale: #f5e8cc; --white: #ffffff; --text-muted: rgba(255,255,255,0.65); --text-dim: rgba(255,255,255,0.38); --serif: 'DM Serif Display', Georgia, serif; --sans: 'DM Sans', system-ui, sans-serif; } #ansa-reg *, #ansa-reg *::before, #ansa-reg *::after { box-sizing: border-box; margin: 0; padding: 0; } #ansa-reg { font-family: var(--sans); color: var(--white); background: var(--navy); } #ansa-reg .reg-block { padding: 3rem 2rem; } #ansa-reg .reg-block + .reg-block { border-top: 1px solid rgba(200,146,42,0.15); } #ansa-reg .reg-block.alt { background: var(--navy-mid); } #ansa-reg .section-label { font-size: 0.72rem; letter-spacing: 0.18em; text-transform: uppercase; color: var(--gold); font-weight: 500; margin-bottom: 1rem; display: flex; align-items: center; gap: 0.6rem; } #ansa-reg .section-label::after { content: ''; display: block; height: 1px; width: 2rem; background: var(--gold); opacity: 0.6; } #ansa-reg h2 { font-family: var(--serif); font-size: clamp(1.6rem, 3vw, 2.4rem); line-height: 1.15; margin-bottom: 1.25rem; color: var(--white); } #ansa-reg h2 em { font-style: italic; color: var(--gold-light); } #ansa-reg p { font-size: 0.95rem; color: var(--text-muted); line-height: 1.8; margin-bottom: 1rem; } #ansa-reg ul { list-style: none; margin: 0 0 1.5rem; padding: 0; display: flex; flex-direction: column; gap: 0.5rem; } #ansa-reg ul li { font-size: 0.9rem; color: var(--text-muted); line-height: 1.5; display: flex; gap: 0.75rem; align-items: flex-start; } #ansa-reg ul li::before { content: ''; display: block; width: 5px; height: 5px; border-radius: 50%; background: var(--gold); flex-shrink: 0; margin-top: 0.45rem; } #ansa-reg .event-meta { display: grid; grid-template-columns: repeat(auto-fit, minmax(200px, 1fr)); gap: 0; margin-top: 2rem; border: 1px solid rgba(200,146,42,0.15); } #ansa-reg .meta-item { padding: 1.1rem 1.25rem; border-right: 1px solid rgba(200,146,42,0.15); } #ansa-reg .meta-item:last-child { border-right: none; } #ansa-reg .meta-label { font-size: 0.68rem; letter-spacing: 0.14em; text-transform: uppercase; color: var(--gold); margin-bottom: 0.3rem; font-weight: 500; } #ansa-reg .meta-value { font-size: 0.9rem; color: var(--white); } #ansa-reg .meta-value a { color: var(--gold-light); text-decoration: none; border-bottom: 1px solid rgba(200,146,42,0.3); } /* SPEAKERS */ #ansa-reg .speakers-grid { display: flex; flex-direction: column; gap: 0; border: 1px solid rgba(200,146,42,0.12); margin-top: 2rem; } #ansa-reg .speaker-row { display: flex; align-items: flex-start; border-bottom: 1px solid rgba(200,146,42,0.12); } #ansa-reg .speaker-row:last-child { border-bottom: none; } #ansa-reg .speaker-img-col { background: var(--navy-light); overflow: hidden; width: 120px; height: 120px; flex-shrink: 0; align-self: flex-start; } #ansa-reg .speaker-img-col img { width: 120px; height: 120px; object-fit: cover; object-position: top center; display: block; } #ansa-reg .speaker-img-col.no-img { display: flex; align-items: center; justify-content: center; width: 120px; height: 120px; } #ansa-reg .speaker-initials { font-family: var(--serif); font-size: 2.5rem; color: var(--gold); opacity: 0.5; } #ansa-reg .speaker-info { padding: 1.75rem 2rem; background: var(--navy); } #ansa-reg .speaker-row:nth-child(even) .speaker-info { background: var(--navy-mid); } #ansa-reg .speaker-num { font-size: 0.68rem; letter-spacing: 0.15em; color: var(--gold); margin-bottom: 0.5rem; font-weight: 500; text-transform: uppercase; } #ansa-reg .speaker-name { font-family: var(--serif); font-size: 1.5rem; color: var(--white); margin-bottom: 0.25rem; line-height: 1.2; } #ansa-reg .speaker-org { font-size: 0.8rem; color: var(--gold); margin-bottom: 1.1rem; letter-spacing: 0.02em; } #ansa-reg .speaker-bio { font-size: 0.88rem; color: var(--text-muted); line-height: 1.75; margin-bottom: 1.1rem; } #ansa-reg .speaker-topic { font-size: 0.85rem; color: var(--gold-pale); line-height: 1.5; font-style: italic; padding-top: 1rem; border-top: 1px solid rgba(200,146,42,0.2); } #ansa-reg .speaker-topic strong { font-style: normal; font-size: 0.7rem; letter-spacing: 0.12em; text-transform: uppercase; color: var(--gold); font-weight: 500; display: block; margin-bottom: 0.3rem; } /* MASTERCLASS */ #ansa-reg .mc-img { width: 100%; height: auto; display: block; margin-bottom: 2rem; } #ansa-reg .mc-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 3rem; } #ansa-reg .mc-topics { list-style: none; margin: 0; padding: 0; } #ansa-reg .mc-topics li { padding: 0.85rem 0; border-bottom: 1px solid rgba(255,255,255,0.06); font-size: 0.9rem; color: var(--text-muted); display: flex; gap: 0.75rem; align-items: center; } #ansa-reg .mc-topics li:first-child { border-top: 1px solid rgba(255,255,255,0.06); } #ansa-reg .mc-dot { width: 5px; height: 5px; border-radius: 50%; background: var(--gold); flex-shrink: 0; } #ansa-reg .btn { display: inline-block; padding: 0.85rem 1.75rem; text-decoration: none; font-size: 0.9rem; letter-spacing: 0.04em; border-radius: 3px; margin-top: 1.25rem; margin-right: 0.75rem; } #ansa-reg .btn-primary { background: var(--gold); color: var(--navy); font-weight: 500; } #ansa-reg .btn-primary:hover { background: var(--gold-light); } #ansa-reg .btn-secondary { border: 1px solid rgba(200,146,42,0.4); color: var(--gold-light); } #ansa-reg .note { font-size: 0.82rem; color: rgba(255,255,255,0.4); font-style: italic; border-left: 2px solid rgba(200,146,42,0.25); padding-left: 0.75rem; margin-top: 1rem; line-height: 1.7; } /* CONTRIBUTE */ #ansa-reg .contribute-note { font-size: 0.85rem; color: rgba(255,255,255,0.45); font-style: italic; border-left: 2px solid rgba(200,146,42,0.3); padding-left: 0.85rem; margin-bottom: 1.75rem; line-height: 1.7; } #ansa-reg .type-pills { display: flex; flex-wrap: wrap; gap: 0.6rem; margin-bottom: 2rem; } #ansa-reg .type-pill { font-size: 0.8rem; padding: 0.35rem 0.85rem; border: 1px solid rgba(200,146,42,0.3); color: rgba(255,255,255,0.65); border-radius: 2px; } /* ENQUIRIES */ #ansa-reg .enquiries { display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; gap: 1.5rem; } #ansa-reg .enquiries h3 { font-family: var(--serif); font-size: 1.6rem; margin-bottom: 0.5rem; } #ansa-reg .enquiries a.email { color: var(--gold-light); text-decoration: none; font-size: 1rem; border-bottom: 1px solid rgba(200,146,42,0.35); padding-bottom: 0.15rem; } @media (max-width: 700px) { #ansa-reg .speaker-row { grid-template-columns: 1fr; } #ansa-reg .speaker-img-col { width: 80px; height: 80px; } #ansa-reg .mc-grid { grid-template-columns: 1fr; gap: 1.5rem; } #ansa-reg .event-meta { grid-template-columns: 1fr; } #ansa-reg .meta-item { border-right: none; border-bottom: 1px solid rgba(200,146,42,0.15); } }&lt;/style&gt;
&lt;link href="https://fonts.googleapis.com/css2?family=DM+Serif+Display:ital@0;1&amp;amp;family=DM+Sans:opsz,wght@9..40,300;9..40,400;9..40,500&amp;amp;display=swap" rel="stylesheet"&gt;

&lt;div id="ansa-reg"&gt;
  &lt;!-- EVENT DESCRIPTION --&gt;

  &lt;div class="reg-block"&gt;
    &lt;div class="section-label"&gt;
      About the Conference
    &lt;/div&gt;

    &lt;h2&gt;Neurotherapy &lt;em&gt;Across the Lifespan&lt;/em&gt;&lt;/h2&gt;

    &lt;p&gt;The 2026 ANSA Conference is an Australasian event bringing together clinicians and practitioners working across neurofeedback, neuromodulation, and applied neuroscience, along with educators, students, and other professionals with an interest in the field.&lt;/p&gt;

    &lt;p&gt;Through presentations, speakers, and shared clinical experience, the conference provides a strong learning environment alongside opportunities to connect with like-minded professionals. With a focus on real-world application, it explores how these approaches are applied in practice to support assessment, intervention, and outcomes across the lifespan.&lt;/p&gt;

    &lt;p&gt;This conference is suited to:&lt;/p&gt;

    &lt;ul&gt;
      &lt;li&gt;Clinicians using or exploring neurofeedback and neuromodulation approaches&lt;/li&gt;

      &lt;li&gt;Practitioners seeking to apply EEG and QEEG findings to inform treatment decisions&lt;/li&gt;

      &lt;li&gt;Professionals working with children, adolescents, and adults across the lifespan&lt;/li&gt;

      &lt;li&gt;Mental health professionals, educators, and referring professionals integrating evidence-informed approaches&lt;/li&gt;

      &lt;li&gt;Students and early-career professionals developing skills in neurotherapy and applied neuroscience&lt;/li&gt;

      &lt;li&gt;Clinicians at all stages of experience, from those starting out through to experienced practitioners refining their approach&lt;/li&gt;
    &lt;/ul&gt;

    &lt;div class="event-meta"&gt;
      &lt;div class="meta-item"&gt;
        &lt;div class="meta-label"&gt;
          Conference
        &lt;/div&gt;

        &lt;div class="meta-value"&gt;
          19th ANSA Conference 2026
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="meta-item"&gt;
        &lt;div class="meta-label"&gt;
          Theme
        &lt;/div&gt;

        &lt;div class="meta-value"&gt;
          Neurotherapy Across the Lifespan
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="meta-item"&gt;
        &lt;div class="meta-label"&gt;
          Dates
        &lt;/div&gt;

        &lt;div class="meta-value"&gt;
          12–13 September 2026
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="meta-item"&gt;
        &lt;div class="meta-label"&gt;
          Venue
        &lt;/div&gt;

        &lt;div class="meta-value"&gt;
          &lt;a href="https://www.qthotels.com/gold-coast/" target="_blank"&gt;QT Hotel, Gold Coast, Queensland&lt;/a&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;!-- SPEAKERS --&gt;

  &lt;div class="reg-block alt"&gt;
    &lt;div class="section-label"&gt;
      Confirmed Speakers
    &lt;/div&gt;

    &lt;h2&gt;2026 Speaker Lineup&lt;/h2&gt;

    &lt;div class="speakers-grid"&gt;
      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Tiff.jpg" alt="Dr Tiff Thompson"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            01 / Keynote
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Dr Tiff Thompson
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            PhD / CEO, School of Neurotherapy &amp;amp; NeuroField Neurotherapy
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Dr Tiff Thompson is a clinical neuroscientist, licensed therapist, educator, and EEG technologist. She is the CEO and Founder of The School of Neurotherapy, an online educational platform offering specialised curricula in Quantitative EEG, Board Certification in Neurotherapy, and Neuromodulation education. Dr Thompson is also CEO and founder of NeuroField Neurotherapy, a Santa Barbara clinic addressing mental health, brain injury, and neurodiverse conditions.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;Normal Paediatric EEG and Childhood Disorders
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Nick.jpg" alt="Dr Nicholas Dogris"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            02 / Keynote
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Dr Nicholas Dogris
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            PhD, BCN, QEEG-D / Licensed Psychologist &amp;amp; CEO, NeuroField Inc.
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Dr Nicholas Dogris is a licensed psychologist, neuroscientist, and pioneering neurotechnology innovator with over 25 years of clinical and research experience in EEG-based neurotherapy. He is CEO and co-founder of NeuroField, Inc., where he helped develop advanced EEG-synchronised neurostimulation and neuromodulation systems. Dr Dogris trains clinicians worldwide and practises in Santa Barbara, California.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;Stewards of the Signal: AI in Computational Neuroscience — Past, Present, and the Ethics of What Comes Next
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Jay.png" alt="Jay Gunkelman"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            03 / Keynote
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Jay Gunkelman
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            QEEG-D Emeritus / Global EEG Authority
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Jay Gunkelman is one of the most recognised figures in clinical EEG and QEEG worldwide. With decades of experience interpreting EEG across clinical and research settings, he has trained thousands of practitioners internationally and remains a defining voice in the field of applied neuroscience.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;DSM-5 and Current Clinical EEG Interpretation: How Did We Get This Screwed Up?
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Siegfried.jpeg" alt="Dr Siegfried Othmer"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            04 / Keynote
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Dr Siegfried Othmer
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            PhD / EEG Institute
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Dr Siegfried Othmer is a pioneer in neurofeedback research and clinical application. As a physicist and neuroscientist, he co-founded the EEG Institute and has spent decades developing and refining neurofeedback protocols used with a wide range of clinical populations. His work spans the full lifespan, from early developmental conditions through to age-related decline.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;From Infancy to Infirmity: Neuromodulation Through the Lifespan
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col no-img"&gt;
          &lt;div class="speaker-initials"&gt;
            JM
          &lt;/div&gt;
        &lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            05
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Dr Jules Mitchell
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            PhD / Senior Research Scientist, Brain &amp;amp; Mind Hub &amp;amp; Thompson Brain &amp;amp; Mind Healthcare
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Dr Jules Mitchell is a neuroscience researcher dedicated to bridging neuroimaging and clinical practice for real-world impact. He holds a Doctorate in Psychiatry and Neuroscience, a Master of Neuroscience, and a Bachelor of Psychological Science (First Class Honours). His work sits at the intersection of cognitive neuroscience, clinical psychiatry, and advanced EEG analysis, with a focus on non-linear brain dynamics and predicting treatment outcomes.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;Individualised 19-Channel Z-score swLORETA Neurofeedback Case Series
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Barb.jpg" alt="Dr Barbara Minton"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            06
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Dr Barbara Minton
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            PhD / Private Practice
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Dr Barbara Minton is a neurotherapy practitioner with extensive experience in clinical neurofeedback and applied neuroscience. Working in private practice, she brings a deep interest in the intersection of sound, music, and brain regulation, and has developed approaches to music-based entrainment for clinical use.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;The Power of Music as Entrainment and Why We Should All Be Using It
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

      &lt;div class="speaker-row"&gt;
        &lt;div class="speaker-img-col"&gt;&lt;img src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/Speakers/Andrea.png" alt="Assoc. Prof. Andrea Phillipou"&gt;&lt;/div&gt;

        &lt;div class="speaker-info"&gt;
          &lt;div class="speaker-num"&gt;
            07
          &lt;/div&gt;

          &lt;div class="speaker-name"&gt;
            Assoc. Prof. Andrea Phillipou
          &lt;/div&gt;

          &lt;div class="speaker-org"&gt;
            Head of Eating Disorders Research, Orygen
          &lt;/div&gt;

          &lt;p class="speaker-bio"&gt;Associate Professor Andrea Phillipou is a leading clinical neuroscientist whose research focuses on the neurobiology and treatment of eating disorders. As Head of Eating Disorders Research at Orygen, she leads work exploring neurostimulation as a therapeutic approach for anorexia nervosa, contributing to a growing evidence base for brain-based interventions in this field.&lt;/p&gt;

          &lt;div class="speaker-topic"&gt;
            &lt;strong&gt;Presentation&lt;/strong&gt;Neurostimulation in Anorexia Nervosa
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;!-- MASTERCLASS --&gt;

  &lt;div class="reg-block"&gt;
    &lt;div class="section-label"&gt;
      Post-Conference Training
    &lt;/div&gt;

    &lt;h2&gt;School of Neurotherapy&lt;br&gt;
    All-Levels Masterclass&lt;/h2&gt;&lt;img class="mc-img" src="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/2026%20nf%20all-levels.png" alt="2026 School of Neurotherapy All-Levels Masterclass"&gt;

    &lt;div class="mc-grid"&gt;
      &lt;div&gt;
        &lt;p&gt;&lt;strong style="color:#e8b14a;"&gt;14–18 September 2026 • Available in person and online&lt;/strong&gt;&lt;/p&gt;

        &lt;p&gt;This intensive five-day training is designed to bring clinicians and technicians up to speed on the full range of NeuroField technologies and applications. Created for professionals of all experience levels, this comprehensive course combines didactic lectures with hands-on training.&lt;/p&gt;

        &lt;p&gt;Participants will learn practical techniques for collecting and interpreting brain data, applying neuromodulation protocols, and translating neurophysiological insights into clinical treatment strategies.&lt;/p&gt;

        &lt;p class="note"&gt;There is no need to own or purchase NeuroField systems to attend — the training is relevant across many systems. The NeuroField EEG acquisition software is compatible with Mitsar amplifiers and others.&lt;/p&gt;&lt;a href="https://www.schoolofneurotherapy.com/australia-all-levels-training-september-2026" class="btn btn-primary"&gt;View Masterclass Details&lt;/a&gt; &lt;a href="https://www.schoolofneurotherapy.com/assessments/2148646937" class="btn btn-secondary"&gt;Provide Training Feedback&lt;/a&gt;
      &lt;/div&gt;

      &lt;div&gt;
        &lt;ul class="mc-topics"&gt;
          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;EEG acquisition and recording
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;QEEG analysis and interpretation
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;Event-related potentials (ERPs)
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;Neurostimulation approaches
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;Neurofeedback applications
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;Case formulation and protocol development
          &lt;/li&gt;

          &lt;li&gt;
            &lt;div class="mc-dot"&gt;&lt;/div&gt;Hands-on practical sessions
          &lt;/li&gt;
        &lt;/ul&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;!-- CALL FOR CONTRIBUTIONS --&gt;

  &lt;div class="reg-block alt"&gt;
    &lt;div class="section-label"&gt;
      Call for Contributions
    &lt;/div&gt;

    &lt;h2&gt;Share Your Work&lt;/h2&gt;

    &lt;p&gt;Submissions are open for clinicians, researchers, and practitioners to contribute to the conference program. Contributions may include research presentations, clinical case discussions, workshops, or applied practice insights aligned with neurotherapy across the lifespan.&lt;/p&gt;

    &lt;p class="contribute-note"&gt;Unable to present this year? We encourage you to submit your work for consideration at the 2027 ANSA Conference.&lt;/p&gt;

    &lt;div class="type-pills"&gt;
      &lt;span class="type-pill"&gt;Research Presentations&lt;/span&gt; &lt;span class="type-pill"&gt;Clinical Case Discussions&lt;/span&gt; &lt;span class="type-pill"&gt;Workshops&lt;/span&gt; &lt;span class="type-pill"&gt;Applied Practice Insights&lt;/span&gt; &lt;span class="type-pill"&gt;Panel Participation&lt;/span&gt;
    &lt;/div&gt;&lt;a href="https://appliedneuroscience.org.au/resources/ANSA%20Conference%202026/ANSA%202026%20Call%20for%20Contributions.pdf" class="btn btn-primary"&gt;Download Contribution Guidelines&lt;/a&gt;
  &lt;/div&gt;&lt;!-- ENQUIRIES --&gt;

  &lt;div class="reg-block"&gt;
    &lt;div class="enquiries"&gt;
      &lt;div&gt;
        &lt;h3&gt;Questions? Get in Touch.&lt;/h3&gt;

        &lt;p&gt;For conference enquiries, sponsorship opportunities, or to get involved with the organising committee.&lt;/p&gt;&lt;a href="mailto:secretary@appliedneuroscience.org.au" class="email"&gt;secretary@appliedneuroscience.org.au&lt;/a&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;</description>
      <link>https://appliedneuroscience.org.au/event-6569067</link>
      <guid>https://appliedneuroscience.org.au/event-6569067</guid>
      <dc:creator />
    </item>
  </channel>
</rss>